Stay updated on Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page.

Latest updates to the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new Revision: v3.4.2 was added to the history, and the older Notice about funding and Revision: v3.4.1 entry were removed.SummaryDifference0.7%

- Check21 days agoChange DetectedA government funding notice banner was added and the site revision tag updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedA glossary toggle (Show glossary) and color-coded change indicators were added to the history view, while the No FEAR Act Data label and the older Revision: v3.3.4 text were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check35 days agoChange DetectedA new revision entry v3.3.4 was added and an older entry v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the history. The HHS Vulnerability Disclosure entry (Revision: v3.3.2) was removed.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page history now includes a new revision entry v3.3.2, and the previous revision v3.3.1 has been removed.SummaryDifference0.1%

Stay in the know with updates to Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page.